Navigation Links
Summary Letter to Hadasit Bio-Holdings Ltd. Shareholders
Date:10/26/2011

a peptide-based drug for the treatment of strokes, myocardial infarction, pulmonary embolism, and venous infarction – conditions that have large target markets evaluated at billions of dollars per year.  The drug is based on the research of Prof. Abd Higazi, from Hadassah Hospital and the University of Pennsylvania. In June 2011, Thrombotech announced the start of a Phase II trial in Israel and the plans to expand the trial to some six additional sites in Israel and around the world. A regulatory permit from India has been granted and the beginning of the trial in other Israeli sites in Europe and the US is expected in Q1 of 2012.

ProtAb Ltd.

ProtAb is focused on the development of drugs for the treatment of Rheumatoid Arthritis and other autoimmune diseases. The drug is based on research by Prof. Yaakov Naparstek, the Head of Internal Medicine at Hadassah Hospital.  After successfully producing humanized antibodies, the company is in the final stages of drug scale-up under GMP conditions, and is in preparation for Phase I/II clinical trials -- which are expected to commence at the beginning of 2012.

Enlivex Ltd.

Enlivex is developing cell therapy for autoimmune diseases, and is currently nearing the end of a Phase I/II clinical trial. From initial findings received from treatment groups, the treatment seems to be safe and effective in reducing graft-versus-host disease (GVHD) in patients receiving bone marrow transplants. The company believes that it can receive approval from the FDA for orphan drug recognition, a status that permits the speeding up of regulatory procedures and provides commercial advantages. There are ongoing negotiations with potential partners – financial and scientific alike.  

BioMarCare Technologies Ltd.

BioMarCare Technologies announced the receipt of a prestigious grant from the BIRD Fund ($900,000) for the support of a joint proj
'/>"/>

SOURCE Hadasit Bio-Holdings Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xian Qinba Xintong Medical Ltd.
2. CTI Receives NASDAQ Letter
3. Synvista Therapeutics Posts Letter to Stockholders on Web Site
4. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
5. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
6. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
7. Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
8. Cell Therapeutics to Request a Hearing With NASDAQ Following Receipt of Staff Determination Letter
9. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
10. Caraco Pharmaceutical Laboratories, Ltd. Receives FDA Warning Letter
11. deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... July 23, 2014 International research and ... that its biobanking project, Provia Laboratories , has ... growing Advisory Board. Scott Wolf , CEO of ... Dr. Vaught onboard with Provia’s ever-expanding Advisory Board. His ... Provia’s management team brings to this field, should help ...
(Date:7/23/2014)... worldwide conservation efforts have made great strides in saving ... China, there are over 65 giant panda reserves that ... despite these efforts, just 1596 pandas remain in the ... zoos hope to save the panda by improving genetic ... the wild. Just how are these high-profile programs doing ...
(Date:7/23/2014)... Researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), the Vienna ... Lublin have succeeded in embedding nearly perfect semiconductor ... method of producing hybrid nanowires, very fast and ... single chip in the future. The research results ... Research . , Nano-optoelectronics are considered the cornerstone ...
(Date:7/23/2014)... 23, 2014  AuraSense Therapeutics, the pioneer in developing ... regulatory and immunotherapeutic agents, announced today that ... Therapeutics, executive leadership team as chief financial ... to joining AuraSense Therapeutics, Mr. Snyder was ... of Cellular Dynamics International Inc., where he ...
Breaking Biology Technology:Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 3Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 4A crystal wedding in the nanocosmos 2AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer 2
... Pharma AG today,announced that the US Food and ... (IND) application submitted by Nitec for the,initiation of ... results of a European Phase III trial (CAPRA-1;,Circadian ... dossier for marketing authorization in Europe. The FDA,s,acceptance ...
... and advantageous for the U.S. Army,s Chemical Materials Agency ... waste during regular chemical agent disposal operations, says a ... committee that wrote the report also determined that the ... the submission of data from previous trial burns -- ...
... Pacific Northwest National Laboratory,have discovered a way to ... creation of a portable biosensor that can address ... nerve agents, the need to quickly distinguish between ... , The sensor components resemble a pregnancy test ...
Cached Biology Technology:Nitec's IND Application for Clinical Development With Lodotra Accepted by the FDA 2Nitec's IND Application for Clinical Development With Lodotra Accepted by the FDA 3Report recommends off-site disposal of secondary waste 2Report recommends off-site disposal of secondary waste 3Report recommends off-site disposal of secondary waste 4Truly sick or simply scared? 2
(Date:7/23/2014)... Chrysomya megacephala is commonly found in dead ... the time of death, referred to as the post ... C. megacephala from Tamil Nadu is provided ... molecular characterization through generation of DNA barcoding. This study, ... access Biodiversity Data Journal . , Chrysomya ...
(Date:7/23/2014)... struggle to deal with ever-growing piles of electronic waste ... just how much there is and where it really ... Science & Technology , their study found that nearly ... into just seven developing countries with major potential ... Knut Breivik and colleagues note that the export from ...
(Date:7/23/2014)... sulfur-oxidizing bacterial group called SUP05 will play an increasingly ... world,s oceans as oxygen minimum zones expand, according to ... the National Academy of Sciences . , University of ... anoxic fjord, Canada,s Saanich Inlet, to chart how microbial ... "Our study paints a very detailed picture of how ...
Breaking Biology News(10 mins):Dead body feeding larvae useful in forensic investigations 2Research charts the ecological impact of microbial respiration in the oxygen-starved ocean 2
... Connie Hedegaard, the EU commissioner for Climate Action, ... new Nordic centre for Europe,s main climate innovation ... entrepreneurs, businesses, climate professionals, students and government officials ... European partnership to work on innovative solutions for ...
... and technology (S&T) eroded further during the last decade, ... their innovation capacities. According to a report released today ... body of the National Science Foundation (NSF) and an ... economies, taken together, now perform a larger share of ...
... D.C., February 6, 2014Dietary supplement users take these ... effort to develop a healthier lifestyle, according to ... , a peer-reviewed scientific publication. The review, "Health ... Nutrition Journal .2014, 13:14), co-authored by Council for ...
Cached Biology News:European Union launches Nordic climate innovation center 2European Union launches Nordic climate innovation center 3US lead in science and technology shrinking 2US lead in science and technology shrinking 3US lead in science and technology shrinking 4Scientific review points to supplement users engaging in a pattern of healthy habits 2